Assessment of the activity of blinatumomab in concomitant association with intensive chemotherapy
Latest Information Update: 10 Aug 2022
At a glance
- Drugs Asparaginase (Primary) ; Blinatumomab (Primary) ; Cytarabine (Primary) ; Dexamethasone (Primary) ; Etoposide (Primary) ; Mitoxantrone (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
Most Recent Events
- 10 Aug 2022 New trial record
- 01 Aug 2022 Results published in the British Journal of Haematology